References
- Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011;43:1-11. https://doi.org/10.4143/crt.2011.43.1.1
- Lin JY, DuBeshter B, Angel C, Dvoretsky PM. Morbidity and recurrence with modifications of radical vulvectomy and groin dissection. Gynecol Oncol 1992;47:80-6. https://doi.org/10.1016/0090-8258(92)90081-S
- Gould N, Kamelle S, Tillmanns T, et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol 2001;82:329-32. https://doi.org/10.1006/gyno.2001.6266
- Moore DH. Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: are two therapies better than one? Gynecol Oncol 2009;113:379-83. https://doi.org/10.1016/j.ygyno.2009.01.004
- Crosbie EJ, Slade RJ, Ahmed AS. The management of vulval cancer. Cancer Treat Rev 2009;35:533-9. https://doi.org/10.1016/j.ctrv.2009.01.005
- Wahlen SA, Slater JD, Wagner RJ, et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer 1995;75:2289-94. https://doi.org/10.1002/1097-0142(19950501)75:9<2289::AID-CNCR2820750917>3.0.CO;2-4
- Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2003;57:409-18. https://doi.org/10.1016/S0360-3016(03)00591-1
- Barton DP. The prevention and management of treatment related morbidity in vulval cancer. Best Pract Res Clin Obstet Gynaecol 2003;17:683-701. https://doi.org/10.1016/S1521-6934(03)00045-2
- Landoni F, Maneo A, Zanetta G, et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 1996;61:321-7. https://doi.org/10.1006/gyno.1996.0150
- Gerszten K, Selvaraj RN, Kelley J, Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol 2005;99:640-4. https://doi.org/10.1016/j.ygyno.2005.07.126
- Lupi G, Raspagliesi F, Zucali R, et al. Combined preoperative chemoradiotherapy followed by radical surgery in loc ally advanced vulvar carcinoma: a pilot study. Cancer 1996;77:1472-8. https://doi.org/10.1002/(SICI)1097-0142(19960415)77:8<1472::AID-CNCR8>3.0.CO;2-E
- Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991;164:997-1003. https://doi.org/10.1016/0002-9378(91)90573-A
- Landrum LM, Skaggs V, Gould N, Walker JL, McMeekin DS. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation. Gynecol Oncol 2008;108:584-90. https://doi.org/10.1016/j.ygyno.2007.11.010
- Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:79-85. https://doi.org/10.1016/S0360-3016(98)00193-X
- Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6. https://doi.org/10.1016/0360-3016(95)00060-C
- Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for nodepositive vulvar cancer: a randomized controlled trial. Obstet Gynecol 2009;114:537-46. https://doi.org/10.1097/AOG.0b013e3181b12f99
- Jang WI, Wu HG, Park CI, et al. Management of regional lymph nodes in localized vulvar carcinoma. J Korean Soc Ther Radiol Oncol 2008;26:1-9. https://doi.org/10.3857/jkstro.2008.26.1.1
- Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26:884-9. https://doi.org/10.1200/JCO.2007.14.0566
- Beriwal S, Coon D, Heron DE, et al. Preoperative intensitymodulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol Oncol 2008;109:291-5. https://doi.org/10.1016/j.ygyno.2007.10.026
- Montana GS, Thomas GM, Moore DH, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2000;48:1007-13. https://doi.org/10.1016/S0360-3016(00)00762-8
- Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol 2008;108:577-83. https://doi.org/10.1016/j.ygyno.2007.11.011
- Talaat A, Brinkmann D, Nagar Y, Hogston P, Khoury G, Woolas R. Experience in the management of patients older than 80 years with vulval cancer. Int J Gynecol Cancer 2009;19:752-5. https://doi.org/10.1111/IGC.0b013e31819d7d31
- Hou JL, Wu LY, Zhang HT, Lv NN, Huang Y, Yu GZ. Clinicopathologic characteristics of 12 patients with vulvar sweat gland carcinoma. Int J Gynecol Cancer 2010;20:874-8. https://doi.org/10.1111/IGC.0b013e3181e1c167
- Tans L, Ansink AC, van Rooij PH, Kleijnen C, Mens JW. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol 2011;34:22-6. https://doi.org/10.1097/COC.0b013e3181cae6a1
Cited by
- Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study vol.33, pp.3, 2012, https://doi.org/10.3857/roj.2015.33.3.198
- Vulvar cancer in Tunisia: Epidemiological and clinicopathological features multicentric study vol.29, pp.2, 2017, https://doi.org/10.1016/j.jnci.2017.02.001
- A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma vol.18, pp.1, 2012, https://doi.org/10.1186/s12967-020-02523-5